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Abstract
Viewing the trajectory of a patient as a dynamical system, a recurrent neural network was
developed to learn the course of patient encounters in the Pediatric Intensive Care Unit
(PICU) of a major tertiary care center. Data extracted from Electronic Medical Records
(EMR) of about 12000 patients who were admitted to the PICU over a period of more
than 10 years were leveraged. The RNN model ingests a sequence of measurements which
include physiologic observations, laboratory results, administered drugs and interventions,
and generates temporally dynamic predictions for in-ICU mortality at user-specified times.
The RNN’s ICU mortality predictions offer significant improvements over those from two
clinically-used scores and static machine learning algorithms.
1. Introduction
1.1 Background on severity and mortality scores
Numerous severity of illness (SOI) and mortality scoring systems have been developed over
the past three decades [Le Gall (2005); Strand and Flaatten (2008)]. Two of the earliest
and commonly used scores are Acute Physiology and Chronic Health Evaluation (APACHE
II), [Knaus et al. (1985)] and Simplified Acute Physiology Score (SAPS) [Le Gall et al.
(1984)], both of which rely on routine physiologic measurements and the deviations of those
measurements from expert-defined normal values. In pediatric critical care, the Pediatric
Risk of Mortality (PRISM), [Pollack et al. (1988)] score and Pediatric Index of Mortality
(PIM), [Shann et al. (1997)] were developed. Both leverage physiologic data, with PIM
incorporating into its calculations additional information such as pre-ICU procedures and
in-ICU ventilation data from the first hour. Larger databases led to refinements of these
systems; for some examples, see APACHE III in Knaus et al. (1991); SAPS 3 in Moreno
et al. (2005); PRISM 3 in Pollack et al. (1996); PRISM 4 in Pollack et al. (2016); PIM 2
in Slater et al. (2003); PIM 3 in Straney et al. (2013). Pollack (2016) makes a distinction
between scoring for severity of illness or predicting mortality. Regardless of this distinction,
however, the effectiveness of these models are measured via their ability to discriminate
between surviving and non-surviving patients.
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1.2 EMR and advanced computing methods
The adoption of Electronic Medical Records (EMR) has enabled ready access to more vari-
ables and more patients. In response to this ever-growing amount of data, machine learning
techniques increasingly have been used to develop models which forecast patient condition.
The Gaussian process-based scores in Ghassemi et al. (2015) and Alaa et al. (2016) leverage
time-series measurements instead of static values from a fixed time window of the systems
described earlier. Towards personalized scoring, the latter attempts to account for hetero-
geneity by discovering, via unsupervised learning, some number of classes in the population,
then learns the parameters that govern each class. The Rothman index [Rothman et al.
(2013)] also offers continuously updated scores but still generates predictions using a static
snapshot.
The use of neural networks in ICU applications actually goes back more than 20 years,
as reviewed in Hanson III and Marshall (2001) . In general those studies were relatively
small in scale (hundreds of patients). Since then, two primary factors have changed the
landscape. First, larger datasets containing tens of thousands of patients with millions of
measurements are now available. Second, computing hardware advances in the last decade,
particularly Graphics Processing Units (GPUs), have enabled larger, deeper networks to be
trained. These more sophisticated networks have demonstrated remarkable success in wide-
ranging applications such as computer vision [Krizhevsky et al. (2012); He et al. (2015)],
speech recognition [Hinton et al. (2012)], and natural language processing [Mesnil et al.
(2015)].
1.3 Summary of RNN-based mortality model/framework
Recurrent Neural Networks (RNN) were designed to process sequential data. A key feature
is a feedback loop which allows integration of information from previous steps with newly
acquired data. Thus, they provide an elegant infrastructure to process ever-evolving streams
of clinical data. Figure 1 gives a high-level illustration of data ingestion and prediction with
a RNN, and Section 3.1 will describe the mathematical formulation. Each input vector (x)
contains clinical measurements (e.g. physiology and medications). The infrastructure also
allows the user to specify how long into the future predictions are for. Each output vector
(y) contains forecasts such as mortality risk at the specified future time. This work focused
on predicting in-ICU mortality of pediatric patients. Hospital mortality is used because it is
an objective function to assess performance despite its inability to capture more subjective
components of care such as quality of survival [Knaus et al. (1985)]. Also, the sequential
nature of the RNN’s mortality risk predictions provides a dynamic tracking of patient
condition.
2. Data and pre-processing
We leveraged anonymized EMR from the PICU at Children’s Hospital Los Angeles between
December 2002 and March 2016. The data for each patient included static information such
as demographics, diagnoses, and disposition (alive or not) at the end of the ICU encounter.
An encounter is defined as a contiguous admission into the PICU. Each encounter contained
irregularly, sparsely and asynchronously sampled measurements of physiologic observations
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Figure 1: Flow of data in RNN-based framework. When measurements (vector X) become
available at time tn, they are ingested as inputs to the RNN kernel. The RNN
then generates a prediction Y corresponding to a future time specified by the user
through ∆tn.
(e.g. heart rate, blood pressure), laboratory results (e.g. creatine, glucose level), drugs (e.g.
epinephrine, furosemide) and interventions (e.g. intubation, oxygen level).
A single patient can have multiple encounters, and this is an important point for valida-
tion. When the database was split into training and testing sets, all encounters from a single
patient belonged to exactly one of these sets to prevent possible leakage. Encounters that
did not include disposition information were excluded from the final database used for the
results presented here. This database consisted of 12020 patients with 16559 encounters.
Seventy-five percent of the patients were randomly selected and placed into the training set,
and the remaining twenty-five percent into a holdout set for testing. This splitting resulted
in 12460 encounters (with 4.85% mortality) in the training set, and 4099 encounters (with
5.12% mortality) in the holdout set.
To leverage existing deep learning frameworks, the data were first converted into the
matrix format illustrated in Figure 2 with a pre-processing pipeline described below.
2.1 Constituent Aggregation and Normalization
Similar physiologic observations or laboratory measurements were aggregated into a single
variable. For example, non-invasive and invasive measurements of systolic blood pressures
were grouped together into a single systolic blood pressure variable. This aggregation
resulted in approximately 300 different physiologic and treatment variables, a complete list
of which can be found in Appendix A.
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Figure 2: After pre-processing, data for a single patient encounter is in a matrix format.
A single row of data contains values (actual and imputed measurements) from a
single variable. A column of data comprises all measurements at one time point.
All quantities under the same variable were converted into the same unit of measure.
Drugs and some interventions were converted to a binary variables corresponding to ab-
sence or presence of administration. Variables that were not binarized were Z-normalized.
The mean and standard deviation needed for this transformation were computed from the
training set only, and then applied to both the training and holdout sets.
2.2 Imputation
The measurements in the database were sparse, irregularly sampled – time between any two
consecutive time points ranges from a minute to several hours – and asynchronous. At any
time point when at least one variable had a recorded value, the values for all other variables
without a measurement at that point were imputed. The imputation process depended
on the variable type. Any missing measurement of a drug or an intervention variable was
imputed as zero. When a physiologic observation or lab measurement was available, it was
propagated forward until its next reading. However, if a physiologic or laboratory variable
had no recorded value throughout the entire encounter, then that variable was set to zero at
all time points for that encounter. Since physiologic observations were first Z-normalized,
a zero imputation is equivalent to an imputation with the population mean derived from
the training set. Note that no features were age-normalized; instead age was an input as
a physiologic observation. These choices were based on a reasonable assumption about
clinical practice: measurements are taken more frequently when something is happening to
the patient, and less frequently when the patient appears stable.
4
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3. RNN-based Framework
3.1 From dynamical system to RNN
The trajectory of a patient can be viewed as a continuous dynamical system composed of
many variables, P (t) = [vitals, labs,drugs, interventions]T , interacting with each other:
dP (t)
dt
= F
[
P (t)
]
, P (t0) = P0. (1)
In equation (1), F denotes the unknown and complex function governing the variable in-
teractions, while P0 is the state at some initial time, t0. For the PICU setting and data, t0
corresponds to the start time of an ICU encounter.
Finite difference methods are a standard way to solve equation (1) [LeVeque (2007)].
Any such approximation can be cast into the form
P (tn + ∆tn) = G
[
P (tn),∆tn, P (tn−1), . . . , P (tn−k),
]
, (2)
where tn + ∆tn is a specified future time of interest. This can be further abstracted into
the form:
P (tn + ∆tn) = G
[
P (tn),∆tn, H
[
P (tn−1), . . . , P (tn−k)
]]
, (3)
where H is a transformation of data from previous time steps. Equation (3) – which can
be visualized in Figure 3 – is a recurrent relation, and G describes the mapping from past
states into a future state.
Figure 3: Visual diagram of finite difference formulation given in Equation 3.
Independent work by Funahashi (1989) and Hornik et al. (1989) established that any
function with mathematically reasonable properties can be approximated by a neural net-
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work to an arbitrary degree of accuracy, i.e.
G =
∑
i
αiσ
[
Wi
(
P (tn),∆tn, H
[
P (tn−1), . . . , P (tn−k)
])
+ bi
]
︸ ︷︷ ︸
Neural Network: N
+ , (4)
where  is an arbitrarily small real number. The finite difference formulation therefore
becomes
P (tn + ∆tn) ≈ N
[
P (tn),∆tn, H
[
P (tn−1), . . . , P (tn−k)
]]
. (5)
The output of H can be regarded as a hidden state or an internal representation of the
patient’s history, and the mortality risk can be inferred from this integration of history.
The diagram of Figure 3 then leads to the RNN formulation shown in Figure 4, where the
RNN module encapsulates G from Equation (2) and an additional function that transforms
the internal state to some observable manifestation, such as mortality risk, represented by
the output y. The recurrent aspect of the network, i.e. the feedback mechanism, allows
past information to be propagated forward.
Figure 4: The output of the RNN, y, is another transformation
It is worth noting that work by Funahashi and Nakamura (1993) showed a direct path
from dynamical systems to a class of continuous time recurrent neural networks (CTRNN)
provided the original function, F , in Equation (1) meets continuity conditions. Chow and Li
(2000) and Li et al. (2005) extended the theory to handle more general dynamical systems,
including time-variant ones with inputs for control . Applying a finite difference scheme to
the CTRNN leads to a form that is very similar to Equation (5).
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Figure 5: Physiologic observations, laboratory measurements, interventions and drugs at
time tn are inputs to the RNN kernel. The RNN then projects a mortality risk
for time tn + ∆tn, where ∆tn is specified by a user.
3.2 RNN architecture and implementation
Figure 5 illustrates the flow of the PICU data and predictions in the RNN-based infras-
tructure. The input vector to the network at time tn consists of five main groups of mea-
surements from a patient’s ICU encounter:
[
XV (tn), XL(tn), XI(tn), XD(tn),∆tn
]T
. The
vector XV contains the physiologic observations, the vector XL contains laboratory results,
the vector XI comprises the interventions, XD records the administered drugs, and the
scalar ∆tn specifies how far into the future the user wants to forecast. Including ∆tn in the
input vector follows naturally from the finite difference formulation (2) and serves a dual
purpose: it gives the user control and flexibility in time-to-prediction, and it also enables
augmentation of the training data during model development. The output at this time
step is a probability of survival at the future time tn + ∆tn which can be thought of as a
prediction of patient condition at that future time.
A number of RNN architectures have been developed and studied (Greff et al., 2015;
Jozefowicz et al., 2015). The specific one utilized here is the Long Short-Term Memory
(LSTM) architecture of Hochreiter and Schmidhuber (1997). The Keras python deep learn-
ing framework (Chollet, 2015) was used to construct a model comprised of three LSTMs –
see Figure 6 – and train this model to make predictions for in-ICU mortality.
4. Results
The RNN model continuously updates its mortality risk predictions as it intakes new data.
Figure 7 displays these temporally evolving risk scores from two patients. This dynamic
7
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Figure 6: RNN architecture for PICU data
tracking, which is automatic in the RNN, is not done by PIM 2 or PRISM 3. The Rothman
index updates its predictions when new measurements become available, but its update
does not integrate past measurements. In this sense, the Rothman index still processes
time series data in a static manner, while the RNN dynamically integrates data through its
feedback mechanism.
Figure 7: RNN-generated mortality risk of two patients tracked over their ICU encounter.
The dashed yellow lines indicate the 12-hour mark. The patient on the left slowly
deteriorated over the course of a day and did not survive. The patient on the
right started as very high-risk but recovered over the course of a week.
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The RNN’s ICU mortality predictions were compared to those of PIM 2 and PRISM 3,
both of which were pulled directly from the EMR. A logistic regression (LR) and a multi-
layer perceptron (MLP) were also implemented for additional comparisons. The LR, MLP
and RNN models access identical clinical data. Like PIM 2 and PRISM 3, LR and MLP
are static methods, meaning they process a snapshot of data from a fixed window of time
to make a single-time prediction. Again, this is a contrast to the RNN which continuously
integrates incoming data with past information. Both PIM 2 and PRISM 3 use information
collected prior to ICU admission, data which the RNN, MLP and LR models do not access.
In addition, PIM 2 incorporates some data from the first hour in the ICU, while PRISM 3
uses data from the first 12 hours in the ICU.
The ICU mortality predictions of the different models were assessed via Receiver Oper-
ating Characteristic (ROC) curves and corresponding Area Under the Curve (AUC). Figure
8 shows the results on 2849 holdout encounters that had both PIM 2 and PRISM 3 scores.
The RNN model yields an AUC of 93.4% which is significantly higher than the comparative
models [MLP: 88.8% (p < 0.01), LR: 86.1% (p < 0.001), PIM 2: 86.3% (p < 0.001), and
PRISM 3: 88.0% (p < 0.003)]. The LR, MLP and RNN predictions used to generate these
results were all taken from the 12th hour. The difference in performance between the MLP
and RNN provides a rough quantification of the boost that dynamic integration provides
over static computation. The feedback loop gives the RNN a temporal memory which
enables temporal trends – i.e., function derivatives – to be incorporated into the model.
Figure 8: Comparison of ICU mortality predictions from various models: Recurrent Neural
Network, Multi-Layer Perceptron, Logistic Regression, PIM2, and PRISM3. ROC
curves and AUCs were generated from 2849 holdout encounters that had both
PIM 2 and PRISM 3 scores available.
Figure 9 demonstrates the improved predictive capability of the RNN model as a function
of increasing observation time. After only three hours of observation, the RNN’s AUC
surpasses that of PRISM 3 which incorporates 12 hours of observation. As the RNN’s
observation window increases, the accuracy of its prediction continues to increase. This is
a desirable characteristic of a risk score.
9
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Figure 9: Comparison of ICU mortality predictions from RNN model after various lengths
of observation time. These results were aggregated from the same 2849 holdout
encounters in the previous figure. All had least 12 hours of data.
5. Conclusions
Recurrent Neural Networks were applied on ICU EMR to generate in-ICU mortality risk
scores. In addition to providing dynamic tracking of patient condition, the RNN-generated
scores also achieved significantly higher accuracy [AUROC greater than 93%] than the
clinically used systems PIM 2 and PRISM 3. The RNN model also outperformed logistic
regression and multi-layer perceptron models. The increased performance of the RNN
model stemmed from two key factors: access to more variables that characterize a patient
and dynamic integration that allows it to incorporate temporal trends of those variables.
Although approximately 300 variables have been encoded into the model, other data
which are available from the PICU, such as fluid balance, have not been incorporated.
Monitor data, which have higher temporal resolution, also have yet to be included. Fu-
ture work will focus on aggregating these additional data and quantifying their impact on
predictive accuracy.
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Appendix A. Clinical Data Used
Vitals
Abdominal girth Bladder pressure
Capillary refill rate Central Venous Pressure
Cerebral perfusion pressure Diastolic Blood Pressure
EtCO2 Eye Response
GlascowCS Head circumference
Heart rate Height
Intracranial pressure Left pupillary response
Motor Response Near-infrared spectroscopy %
Pulse Oximetry Pupillary response
Respiratory rate Right pupillary response
Systolic Blood Pressure Temperature
Verbal Response Weight
Labs
ABG Base excess ABG FiO2
ABG HCO3 ABG O2 sat %
ABG PCO2 ABG PO2
ABG TCO2 ABG pH
ALT (SGPT) AST (SGOT)
Albumin level Alkaline phosphatase
Amylase B-type Natriuretic Peptide
BUN Bands %
Basophils % Bicarbonate serum
Bilirubin conjugated Bilirubin total
Bilirubin unconjugated Blasts %
C-reactive protein CBG Base excess
CBG FiO2 CBG HCO3
CBG O2 sat % CBG PCO2
CBG PO2 CBG TCO2
CBG pH CSF Bands %
CSF Lymphs % CSF RBC
CSF Segs % CSF WBC
CSF glucose CSF protein
Calcium ionized Calcium total
Chloride Complement C3 serum
Complement C4 serum Creatinine
Culture CSF Culture blood
Culture fungus blood Culture respiratory
Culture urine Culture wound
ESR Eosinophils %
FDP Titer Ferritin level
Fibrinogen GGT
Glucose Haptoglobin
14
Dynamic Mortality Risk Prediction
Labs (cont.)
Hema Hemo
INR Lactate
Lactate Dehydrogenase blood Lactic Acid blood
Lipase Lymphocyte %
MCH MCHC %
MCV MVBG Base excess
MVBG FiO2 MVBG HCO3
MVBG O2 sat % MVBG PCO2
MVBG PO2 MVBG TCO2
MVBG pH Macrocytes
Magnesium level Metamyelocytes %
Monocytes % Myelocytes %
Neutrophils % Oxygentaion index
P/F ratio PT
PTT PaO2/FiO2
Phosphorus level Platelet count
Potassium Protein total
RBC blood RDW %
Reticulocyte count % Schistocytes
Sodium T4 free
TSH Triglycerides
VBG Base excess VBG FiO2
VBG HCO3 VBG O2 sat %
VBG PCO2 VBG PO2
VBG TCO2 VBG pH
Virus White blood cell count
Interventions
Abdominal X ray Alprostadil
Amplitude CT abdomen
CT abdomen/pelvis CT brain
CT chest CT pelvis
Chest X ray Chest/abd X ray
Continuous EEG ECMO hours
ECMO type EPAP
FiO2 Foley catheter
Frequency Hemofiltration/CRRT
IPAP Inspiratory time
MAP MRI brain
Mean airway pressure NIV set rate
Nitric Oxide O2 Flow
PEEP PEEP
Peak Inspiratory Pressure Peritoneal dyalisis
Pressure support Tidal volume delivered
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Interventions (cont.)
Tidal volume expiratory Tidal volume inspiratory
Tidal volume set Tracheostomy
Ventilator rate Ventricular assist device
Volume Tidal
Drugs
Acetaminophen Acetaminophen/Codeine
Acetaminophen/Hydrocodone Acetaminophen/Oxycodone
Acetazolamide Acetylcysteine
Acyclovir Albumin
Albuterol Allopurinol
Alteplase Amikacin
Aminocaproic Acid Aminophylline
Amiodarone Amlodipine
Amoxicillin Amoxicillin/clavulanic acid
Amphotericin B Amphotericin B Lipid Complex
Ampicillin Ampicillin/Sulbactam
Aspirin Atenolol
Atropine Azathioprine
Azithromycin Baclofen
Basiliximab Budesonide
Bumetanide Calcium Chloride
Calcium Glubionate Calcium Gluconate
Captopril Carbamazepine
Carvedilol Caspofungin
Cefazolin Cefepime
Cefotaxime Cefoxitin
Ceftazidime Ceftriaxone
Cefuroxime Cephalexin
Chloral Hydrate Chlorothiazide
Ciprofloxacin HCL Cisatracurium
Clarithromycin Clindamycin
Clonazepam Clonidine HCl
Clotrimazole Cromolyn Sodium
Cyclophosphamide Cyclosporine
Dantrolene Sodium Desmopressin
Dexamethasone Dexmedetomidine
Diazepam Digoxin
Diphenhydramine HCl Dobutamine
Dopamine Dornase Alfa
Doxacurium Chloride Doxorubicin
Doxycycline Hyclate Enalapril
Enoxaparin Epinephrine
Epoetin Erythromycin
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Drugs (cont.)
Esmolol Hydrochloride Etomidate
Factor VII Famotidine
Fentanyl Ferrous Sulfate
Filgrastim Flecainide Acetate
Fluconazole Fluticasone
Fosphenytoin Furosemide
Gabapentin Ganciclovir Sodium
Gentamicin Glycopyrrolate
Haloperidol Heparin
Hydrocortisone Hydromorphone
Ibuprofen Imipenem
Immune Globulin Insulin
Ipratropium Bromide Isoniazid
Isoproterenol Isradipine
Itraconazole Ketamine
Ketorolac Labetalol
Lactobacillus Lansoprazole
Levalbuterol Levetiracetam
Levocarnitine Levofloxacin
Levothyroxine Sodium Lidocaine
Linezolid Lisinopril
Lorazepam Magnesium Sulfate
Meropenem Methadone
Methylprednisolone Metoclopramide
Metolazone Metronidazole
Micafungin Midazolam HCl
Milrinone Montelukast Sodium
Morphine Mycophenolate Mofetl
Naloxone HCL Naproxen
Nesiritide Nifedipine
Nitrofurantoin Nitroglycerine
Nitroprusside Norepinephrine
Nystatin Octreotide Acetate
Olanzapine Ondansetron
Oseltamivir Oxacillin
Oxcarbazepine Oxycodone
Pancuronium Pantoprazole
Penicillin G Sodium Pentobarbital
Phenobarbital Phenylephrine HCl
Phenytoin Piperacillin
Piperacillin/Tazobactam Potassium Chloride
Potassium Phosphate Prednisolone
Prednisone Procainamide
Propofol Propranolol HCl
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Drugs (cont.)
Prostacyclin Protamine
Racemic Epi Ranitidine
Rifampin Risperidone
Rocuronium Sildenafil
Sodium Bicarbonate Sodium Chloride
Sodium Phosphate Spironolactone
Sucralfate Tacrolimus
Terbutaline Theophylline
Ticarcillin Ticarcillin/clavulanic acid
Tobramycin Topiramate
Treprostinil Trimethoprim/Sulfamethoxazole
Tromethamine Ursodiol
Valganciclovir Valproic Acid
Vancomycin Vasopressin
Vecuronium Vitamin E
Vitamin K Voriconazole
Warfarin Sodium
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